BAMF
EWTX icon

BI Asset Management Fondsmaeglerselskab’s Edgewise Therapeutics EWTX Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58K Buy
+1,439
New +$49.6K ﹤0.01% 647
2025
Q2 		– Sell
-1,163
Closed -$26K – 797
2025
Q1 		$26K Sell
1,163
-7,690
-87% -$202K ﹤0.01% 894
2024
Q4 		$236K Buy
+8,853
New +$282K ﹤0.01% 687

Other funds holding EWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's EWTX Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 1,439 shares worth $58K. The stake represents ﹤0.01% of the portfolio and ranks #647 among its holdings. This is a return to the name: BI Asset Management Fondsmaeglerselskab previously reported a position in EWTX as recently as Q1 2025.

BI Asset Management Fondsmaeglerselskab first reported a position in EWTX in Q4 2024 and has held it in 3 quarters since. The position peaked at $236K in Q4 2024. 89 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab held 1,439 shares of Edgewise Therapeutics worth $58K as of Q2 2026.
  • Edgewise Therapeutics was a new BI Asset Management Fondsmaeglerselskab position in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #647 holding.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • BI Asset Management Fondsmaeglerselskab's Edgewise Therapeutics position peaked at $236K in Q4 2024.
  • 89 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.